Nuclear Medicine Imaging of Prostate Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".
Deadline for manuscript submissions: closed (30 March 2020)
Special Issue Editor
Special Issue Information
Dear Colleagues,
Molecular imaging of prostate cancer is currently a rapidly evolving area, combining new technologies such as positron emission tomography and magnetic resonance (PET/MR) imaging, with new developments of radionuclides, targeting various aspects of prostate cancer.
In the last few years, a new class of small molecules targeting the prostate specific membrane antigen (PSMA-tracers) became available. Since then, the use of 68Ga- or 18F-labelled PSMA PET/CT or PET/MR has rapidly increased, due to an excellent contrast-to-noise ratio and high image resolution, thereby improving the detectability of small lesions. For the detection of biochemical recurrence of prostate cancer, PSMA PET soon became an integral part of patient care. Further applications are under investigation, such as staging, biopsy guidance, and therapy response assessment. However, PSMA is not expressed on every prostate cancer. Therefore, further investigation of alternative targets is still needed not only within nuclear medicine but also in molecular pathology to find optimal targets and imaging approaches for every patient.
In this upcoming issue, we intend to focus on prostate imaging using both PSMA or alternative targets (e.g., GRP-receptor, amino acid transport) for the detection or therapy of prostate cancer. Both original research and review articles are welcomed.
Please feel free to contact us and send us your suggestions that you would like to discuss beforehand. We look forward to and welcome your participation in this Special Issue.
Dr. Irene A. Burger
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hybrid imaging
- prostate specific membrane antigen
- therapy response assessment
- radioligand therapy
- staging/restaging
- PSMA negative prostate cancer
- molecular pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
